REPLIGEN CORP Increase (Decrease) in Other Receivables
REPLIGEN CORP (RGEN) reported Increase (Decrease) in Other Receivables of -$128.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2021-02-24
- REPLIGEN CORP increase (decrease) in other receivables for the quarter ending 2020-12-31 was $29.00K, a 77.69% decline year-over-year.
- REPLIGEN CORP increase (decrease) in other receivables for the quarter ending 2020-09-30 was $27.00K, a 69.32% decline year-over-year.
- REPLIGEN CORP increase (decrease) in other receivables for the quarter ending 2020-06-30 was -$36.00K.
- REPLIGEN CORP increase (decrease) in other receivables for the quarter ending 2020-03-31 was -$148.00K.
- REPLIGEN CORP increase (decrease) in other receivables for fiscal 2020 was -$128.00K, a 223.08% decline from fiscal 2019.
- REPLIGEN CORP increase (decrease) in other receivables for fiscal 2019 was $104.00K.
- REPLIGEN CORP increase (decrease) in other receivables for fiscal 2018 was -$7.00K.
- REPLIGEN CORP increase (decrease) in other receivables for fiscal 2017 was -$644.00K, a 198.77% decline from fiscal 2016.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 3 month as first filed | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 9 month as first filed | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $56.00K derived: sum of 2 quarters · filed 2021-02-24 | $20.00K derived: sum of 3 quarters · filed 2021-02-24 | -$128.00K 10-K · filed 2021-02-24 | ||||
| 2020-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$9.00K derived: sum of 2 quarters · filed 2020-11-05 | -$157.00K 10-Q · filed 2020-11-05 | -$27.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2020-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$184.00K 10-Q · filed 2020-07-30 | -$54.00K derived: sum of 3 quarters · filed 2021-02-24 | $34.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2020-03-31 | -$148.00K 10-Q · filed 2020-05-06 | -$18.00K derived: sum of 2 quarters · filed 2021-02-24 | $70.00K derived: sum of 3 quarters · filed 2021-02-24 | $68.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $218.00K derived: sum of 2 quarters · filed 2021-02-24 | $216.00K derived: sum of 3 quarters · filed 2021-02-24 | $104.00K 10-K · filed 2021-02-24 | ||||
| 2019-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $86.00K derived: sum of 2 quarters · filed 2020-11-05 | -$26.00K 10-Q · filed 2020-11-05 | -$182.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$114.00K 10-Q · filed 2020-07-30 | -$270.00K derived: sum of 3 quarters · filed 2021-02-24 | -$61.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$112.00K 10-Q · filed 2020-05-06 | -$268.00K derived: sum of 2 quarters · filed 2021-02-24 | -$59.00K derived: sum of 3 quarters · filed 2021-02-24 | $8.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $53.00K derived: sum of 2 quarters · filed 2021-02-24 | $120.00K derived: sum of 3 quarters · filed 2021-02-24 | -$7.00K 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $276.00K derived: sum of 2 quarters · filed 2019-10-31 | $149.00K 10-Q · filed 2019-10-31 | -$299.00K derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$60.00K 10-Q · filed 2019-08-01 | -$508.00K derived: sum of 3 quarters · filed 2020-02-26 | -$478.00K derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | -$127.00K 10-Q · filed 2019-05-09 | -$575.00K derived: sum of 2 quarters · filed 2020-02-26 | -$545.00K derived: sum of 3 quarters · filed 2020-02-26 | -$599.00K derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | -$448.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$418.00K derived: sum of 2 quarters · filed 2020-02-26 | -$472.00K derived: sum of 3 quarters · filed 2020-02-26 | -$644.00K 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$24.00K derived: sum of 2 quarters · filed 2018-11-01 | -$196.00K 10-Q · filed 2018-11-01 | $476.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$226.00K 10-Q · filed 2018-08-02 | $446.00K derived: sum of 3 quarters · filed 2019-03-01 | $108.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | -$172.00K 10-Q · filed 2018-05-08 | $500.00K derived: sum of 2 quarters · filed 2019-03-01 | $162.00K derived: sum of 3 quarters · filed 2019-03-01 | $231.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $334.00K derived: sum of 2 quarters · filed 2019-03-01 | $403.00K derived: sum of 3 quarters · filed 2019-03-01 | $652.00K 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$269.00K derived: sum of 2 quarters · filed 2017-11-09 | -$20.00K 10-Q · filed 2017-11-09 | $5.00K derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $318.00K 10-Q · filed 2017-08-03 | $343.00K derived: sum of 3 quarters · filed 2018-02-22 | -$123.00K derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $249.00K 10-Q · filed 2017-05-04 | $274.00K derived: sum of 2 quarters · filed 2018-02-22 | -$192.00K derived: sum of 3 quarters · filed 2018-02-22 | -$64.00K derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$441.00K derived: sum of 2 quarters · filed 2018-02-22 | -$313.00K derived: sum of 3 quarters · filed 2018-02-22 | -$158.00K 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | -$466.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$338.00K derived: sum of 2 quarters · filed 2016-11-03 | -$183.00K 10-Q · filed 2016-11-03 | -$62.00K derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $283.00K 10-Q · filed 2016-08-04 | $283.48K 10-Q · filed 2015-08-06 | $404.00K derived: sum of 3 quarters · filed 2017-02-23 | $80.28K derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $155.00K 10-Q · filed 2016-05-05 | $154.53K 10-Q · filed 2015-05-08 | $276.00K derived: sum of 2 quarters · filed 2017-02-23 | -$47.72K derived: sum of 3 quarters · filed 2017-02-23 | $328.82K derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$202.72K derived: sum of 2 quarters · filed 2017-02-23 | $173.82K derived: sum of 3 quarters · filed 2017-02-23 | -$6.56M 10-K · filed 2017-02-23 | -$6.56M 10-K · filed 2015-03-17 | |||
| 2014-09-30 | -$323.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $52.82K derived: sum of 2 quarters · filed 2015-11-05 | -$6.68M 10-Q · filed 2015-11-05 | -$6.68M 10-Q · filed 2014-11-07 | -$6.54M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | $376.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$6.35M 10-Q · filed 2015-08-06 | -$6.22M derived: sum of 3 quarters · filed 2016-02-25 | -$4.94M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | -$6.73M 10-Q · filed 2015-05-08 | -$6.60M derived: sum of 2 quarters · filed 2016-02-25 | -$5.31M derived: sum of 3 quarters · filed 2016-02-25 | -$3.85M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $135.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.42M derived: sum of 2 quarters · filed 2016-02-25 | $2.88M derived: sum of 3 quarters · filed 2016-02-25 | -$2.40M 10-K · filed 2016-02-25 | -$2.40M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.75M derived: sum of 2 quarters · filed 2014-11-07 | -$2.54M 10-Q · filed 2014-11-07 | $2.63M derived: sum of 4 quarters · filed 2015-03-17 | ||||
| 2013-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$3.82M 10-Q · filed 2014-08-11 | $1.35M derived: sum of 3 quarters · filed 2015-03-17 | $1.73M derived: sum of 4 quarters · filed 2015-03-17 | ||||
| 2013-03-31 | -$5.28M 10-Q · filed 2014-05-09 | -$116.99K derived: sum of 2 quarters · filed 2015-03-17 | $266.16K derived: sum of 3 quarters · filed 2015-03-17 | $765.13K derived: sum of 4 quarters · filed 2015-03-17 | ||||
| 2012-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $5.55M derived: sum of 2 quarters · filed 2015-03-17 | $6.05M derived: sum of 3 quarters · filed 2015-03-17 | $5.92M 10-K · filed 2015-03-17 | ||||
| 2012-09-30 | $383.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $882.12K derived: sum of 2 quarters · filed 2013-11-08 | $755.86K 10-Q · filed 2013-11-08 | $1.17M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $498.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $372.71K 10-Q · filed 2013-08-07 | $790.10K derived: sum of 3 quarters · filed 2014-03-14 | $807.10K derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | -$126.25K 10-Q · filed 2013-05-07 | $291.13K derived: sum of 2 quarters · filed 2014-03-14 | $308.13K derived: sum of 3 quarters · filed 2014-03-14 | $567.99K derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $417.38K derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $434.38K derived: sum of 2 quarters · filed 2014-03-14 | $694.24K 10-K · filed 2014-03-14 | $460.24K derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-09-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $276.86K 10-Q · filed 2011-11-09 | $42.86K 10-Q · filed 2012-11-08 | $276.46K derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-06-30 | $259.86K 10-Q · filed 2011-08-05 | $25.86K 10-Q · filed 2012-08-09 | $259.46K derived: sum of 3 quarters · filed 2014-03-14 | $294.46K derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-03-31 | -$234.00K 10-Q · filed 2012-05-10 | -$398.00 derived: sum of 2 quarters · filed 2014-03-14 | $34.60K derived: sum of 3 quarters · filed 2014-03-14 | $216.60K 10-K · filed 2013-03-15 | ||||
| 2010-12-31 | $233.60K derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $268.60K derived: sum of 2 quarters · filed 2014-03-14 | $450.60K 10-K · filed 2014-03-14 | |||||
| 2010-09-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $217.00K 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $182.00K 10-Q · filed 2011-08-05 | |||||||
| 2010-03-31 | $259.20K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |